Vertex Pharmaceuticals

YTD

ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.

CEO

Reshma Kewalramani

CEOReshma Kewalramani

Employees

6,400

Employees6,400

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1989

Founded1989

Employees

6,400

Employees6,400

VRTX Key Statistics

Market cap

118.43B

Market cap118.43B

Price-Earnings ratio

26.77

Price-Earnings ratio26.77

Dividend yield

—

Dividend yield—

Average volume

1.43M

Average volume1.43M

High today

$467.94

High today$467.94

Low today

$452.50

Low today$452.50

Open price

$455.65

Open price$455.65

Volume

1.19M

Volume1.19M

52 Week high

$507.92

52 Week high$507.92

52 Week low

$362.50

52 Week low$362.50

Stock Snapshot

As of today, Vertex Pharmaceuticals(VRTX) shares are valued at $466.59. The company's market cap stands at 118.43B, with a P/E ratio of 26.77.

As of 2026-06-22, Vertex Pharmaceuticals(VRTX) stock has fluctuated between $452.50 and $467.94. The current price stands at $466.59, placing the stock +3.1% above today's low and -0.3% off the high.

The Vertex Pharmaceuticals(VRTX)'s current trading volume is 1.19M, compared to an average daily volume of 1.43M.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $507.92 at its peak.

VRTX News

New York Times 11h

Loophole in Patent Law Brings ‘Miracle Drug’ to Patients Who Can’t Afford It - The New York Times

...

The Motley Fool 2d

If I Had to Start Over With $1,000 in Stocks Today, Here's Exactly What I'd Buy

It's never too late to start investing. Whether the market is rising or falling, you'll always find opportunities to buy quality stocks that may deliver big res...

Simply Wall St 3d

How Strong Pediatric CASGEVY Data Could Impact Vertex Pharmaceuticals’ Gene Therapy Investment Narrative

Vertex Pharmaceuticals recently reported Phase 3 data showing that its CRISPR-based gene therapy CASGEVY produced consistent efficacy and safety in children age...

Analyst ratings

81%

of 36 ratings

Buy

80.6%

Hold

16.7%

Sell

2.8%

More VRTX News

Nasdaq 3d

Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up. Here's What That Means for Both Stocks.

Key Points Vertex Pharmaceuticals and Eli Lilly are both going after the non-opioid pain management market. Vertex Pharmaceuticals has a lead, but both drugma...

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.